Renal Master List of Peer Reviewed Studies

IgA Nephropathy after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34278290/ ANCA glomerulonephritis after Moderna: https://www.kidney-international.org/article/S0085-2538(21)00555-X/fulltext Nephrotic Syndrome following AstraZeneca: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257404/ ANCA associated Glomerulonephritis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34423176/ ANCA associated vasculitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416184/ IgA and crescentic glomerulonephritis following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141343/ Nephrotic syndrome and vasculitis following Pfizer, Moderna, and AstraZeneca: https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfab215/6318785 De novo vasculitis after Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166777/ 3 cases of minimal change disease following 2nd dose of mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34337193/ Minimal Change disease and Severe AKI following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34242687/ Minimal Change Disease Following Pfizer: https://pubmed.ncbi.nlm.nih.gov/33839200/ Minimal Change Disease relapse following Pfizer: https://www.ajkd.org/article/S0272-6386(21)00627-2/fulltext MCD relapse following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137360/ MCD relapse following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098029/ Severe MCD relapse 3 days following Pfizer: https://europepmc.org/article/pmc/pmc8156905 Minimal change disease and AKI following Pfizer: https://www.kidney-international.org/article/S0085-2538(21)00493-2/pdf Minimal Change disease following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149162/ IgA nephropathy in 2 pediatric patients after Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256683/ IgA and crescentic glomerulonephritis following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141343/ 3 cases of IgA nephropathy patients developing exacerbations following mRNA vaccine: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166778/ 2 cases of IgA nephropathy patients developing exacerbations following moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987498/ IgA nephropathy flare up following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079938/ IgA Nephropathy after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34278290/ ITP following Astrazeneca: https://ashpublications.org/blood/article/doi/10.1182/blood.2021012790/476455/Immune-Thrombocytopenic-Purpura-after-vaccination IgA nephropathy in 2 pediatric patients after Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256683/ 2 cases of IgA Nephropathy patients developing hematuria after Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329426/ IgA nephropathy flare-up following vaccination: https://pubmed.ncbi.nlm.nih.gov/34415336/ Membranous nephropathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34419553/ Membranous nephropathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34332960/ ANCA-Associated Vasculitis Following Pfizer-BioNTech: https://www.ajkd.org/article/S0272-6386(21)00742-3/fulltext?fbclid=IwAR1NWbOTsNpAQK6qF-FvAdnlc1gMsYHzklO7PKB8AlHkV-iLnhGScTFpPfo New onset ANCA vasculitis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34280507/